TWi Pharmaceuticals Inc
201-500 Employees · BioTech / Pharmaceutical
About TWi Pharmaceuticals Inc
TWi Pharmaceuticals, Inc. (TWi) is a technology-based special pharmaceutical company focusing on the development and commercialization of "High Barrier Generics" drugs primarily for United States. Unlike the common generic drugs, developing high barrier generic drugs require a full array of expertise, including advanced scientific research, process development, patent analysis, regulatory compliances, and market and competition analysis. TWi focuses on the development of the following two categories of high barrier generic drugs:
Paragraph IV：
For generic drugs, Abbreviated New Drug Applications (ANDAs) are filed with US FDA for approval. These ANDAs are categorized into 4 categories - Paragraph I, II, III and IV. TWi's specialty is in the application of Paragraph IV (PIV) drugs which require strong science and technical know-how . Using our expertise in designing innovative alternative formulation, TWi is able to challenge or bypass the brand manufacturer's patent protection and to provide patients with drugs which have the same efficacy and quality as the branded drugs at a lower cost prior to the brand drugs' patent expiration.
Generics with High Technical Barriers：
For some drugs, although the patent protection for those drugs has already well expired, these drugs are still oligopolized by the original brand company and/or a limited number of generic companies due to high technical or other entry barriers. This type of drugs is also the key development focus for TWi.
TWi Biotechnology, Inc. is a 100% fully-owned subsidiary of TWi Pharmaceuticals, Inc., focusing on the new drug research and development. Using innovation, quality, and efficiency as its core competency, TWi Biotechnology is dedicated on the development of treatment for innate inflammatory related diseases in metabolic, ophthalmology, and dermatology areas. Coupling with TWi's expertise and experience in formulation development, toxicology study, drug delivery system, clinical trial design, regulatory approval, TWi Biotechnology is poised to become the leader in developing treatment for above mentioned therapeutic areas.
Corporate Philosophy
The key to TWi's success is based on 4 elements: Innovation, Integrity, Intelligence, and International. As a specialty pharmaceutical company, TWi thrives on overcoming technical challenges and innovations. At TWi, with our unique ability to integrate various kinds of expertise from R&D all the way to commercial production, we believe that it is our social responsibility to provide high quality and affordable generic and new drugs for patients worldwide.
Corporate Goal
TWi intends to establish itself as a Taiwan-based global pharmaceutical company and to compete in the international market along with its peers in Taiwan. We plan to create sustainable profit with our high technical barrier generic drugs pipeline in the near term. For the mid to long range goal, we plan to create higher growth and value for our shareholders with our new/branded drugs pipeline.
TWi Pharmaceuticals Inc Business Information
Company Name
TWi Pharmaceuticals Inc
Company Type
-
Company Size
201-500
Industry
BioTech / Pharmaceutical
Company SSM No
-
Job Vacancies
0
Got questions about working here? Let the employer answer!
TWi Pharmaceuticals Inc Company Address
台灣台北市內湖區港墘路221巷41號3樓